---
figid: PMC9054332__CUAJ-4-gE187-01
pmcid: PMC9054332
image_filename: CUAJ-4-gE187-01.jpg
figure_link: /pmc/articles/PMC9054332/figure/f1-cuaj-4-e184/
number: Fig. 1
figure_title: ''
caption: 'Prostate cancer screening pathway. aDiscontinue screening if life expectancy
  <10 years; bconsider discontinuation of screening if age >60 and PSA <1 ng/ml; cmore
  frequent testing interval can be considered; the optimal frequency is unknown; di.e.,
  risk calculators, % free PSA, etc. PSA: prostate-specific antigen.'
article_title: UPDATE â€“ 2022 Canadian Urological Association recommendations on prostate
  cancer screening and early diagnosis.
citation: Ross J. Mason, et al. Can Urol Assoc J. 2022 Apr;16(4):E184-E196.
year: '2022'

doi: 10.5489/cuaj.7851
journal_title: Canadian Urological Association Journal
journal_nlm_ta: Can Urol Assoc J
publisher_name: Canadian Medical Association

keywords:
---
